Trials / Recruiting
RecruitingNCT04688190
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 800 (estimated)
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.
Conditions
Timeline
- Start date
- 2020-11-01
- Primary completion
- 2025-03-01
- Completion
- 2030-12-31
- First posted
- 2020-12-29
- Last updated
- 2022-05-17
Locations
26 sites across 10 countries: United States, Australia, Canada, Denmark, France, Germany, Italy, Norway, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT04688190. Inclusion in this directory is not an endorsement.